Skip to main content

Digital Musculoskeletal (MSK) Care Market to grow at 18–20% CAGR driven by smart rehab tools by 2029

 


The global digital musculoskeletal (MSK) care market is expected to grow at a CAGR of 18-20% in the next 5 years. The aging patient population and high prevalence of MSK conditions, the rise in uptake of remote healthcare services post-COVID-19, advancements in wearable technology, significant investment into the digital MSK space, and growing demand to improve outcomes and make MSK care more convenient, accessible, and cost-effective are some of the key factors driving the digital MSK care market. 

Digital musculoskeletal (MSK) care leverages digital health technologies and tools to advance the diagnosis, treatment, and management of musculoskeletal system conditions, affecting motor organs, muscles, tendons, bones, cartilage, ligaments, and nerves. Digital MSK solutions typically include online/virtual consultations, remote monitoring of patient symptoms and progress, digital pain management therapy programs, wellness and prevention programs, and digital platforms for self-assessment, self-management, and education. The objective of these solutions is to reduce the need for in-person visits and make MSK care more convenient, and accessible to improve patient adherence and outcomes.

To request a free sample copy of this report, please visit below
https://meditechinsights.com/digital-musculoskeletal-care-market/request-sample/

The growing global burden of musculoskeletal disorders to propel market growth

Musculoskeletal disorders can have a significant impact on quality of life and healthcare costs. With the growth in the aging population and work-related MSK disorders, the prevalence of MSK conditions and associated functional limitations is rapidly increasing. According to WHO, MSK conditions affect more than 1.7 billion people worldwide and are a leading cause of disability. MSK conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Digital MSK has increasingly gained traction in recent years, mainly post-COVID-19 pandemic, which has led to a rise in remote healthcare services. With the growing burden of MSK and the advantages associated with the use of digital pain management and monitoring solutions, the demand for digital MSK care solutions is expected to grow in the coming years.

Significant investments in digital MSK space to further drive the market growth

The digital health market is witnessing growing investment in companies offering solutions for musculoskeletal conditions. MSK digital health solutions raised $223 mi till June 2024, which was already nearly double that of the previous year’s $125 mi. Some of the recent deals include Sword Health, an AI-powered virtual physical therapy startup, that has raised $30 mi in June 2024 bringing Sword’s total funding to $340 mi and the nine-year-old company’s valuation to $3 bn. In Feb 2023, Digital MSK health company IncludeHealth raised $11 mi in a funding round led by CincyTech with participation from Tamarind Hill and other investors. Such funding would promote innovation in the digital MSK space thereby further boosting the market growth.

Competitive Landscape Analysis

The global digital MSK care market is marked by the presence of innovative and emerging market players such as Hinge Health, Sword Health, Omada Health, Kaia Health, Upswing Health, RecoveryOne, Spinezone, Dario Health, IncludeHealth, Vori Health, getUbetter, RealizedCare; among others. Some of the key strategies adopted by market players include product innovation and development, and strategic partnerships and collaborations.

🔗 Want deeper insights? Download the sample report here:
https://meditechinsights.com/digital-musculoskeletal-care-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global digital musculoskeletal (MSK) care market at the regional- and country-level from 2022 to 2029. The report further segments the market based on solution, condition, and end user.

  • Market Size & Forecast (2022-2029), By Solution, USD Million
    • Online/Virtual Consultations
    • Pain Management Therapy Programs
    • Remote Monitoring
    • Others
  • Market Size & Forecast (2022-2029), By Condition, USD Million
    • Back Pain
    • Foot & Ankle Pain
    • Knee & Lower Leg Pain
    • Neck & Shoulder Pain
    • Pelvis, Hip & Thigh Pain
    • Others
  • Market Size & Forecast (2022-2029), By End User, USD Million
    • Healthcare Providers
    • Healthcare Payers
    • Employers
    • Individuals/Patients
    • Others
  • Market Size & Forecast (2022-2029), By Region, USD Million
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Cell Isolation Market projected to grow at 11% CAGR with R&D in oncology therapies by 2030

  The global cell isolation market is projected to grow at a CAGR of 11% from 2025 to 2030,  driven by rising investments in cell-based research, increasing adoption of cell therapies, and growing demand for biopharmaceutical production. Growth is further supported by technological advancements in isolation methods, increasing R&D activities in regenerative medicine, and expanding clinical applications for isolated cells.  Cell isolation is a fundamental process in life sciences and clinical research, involving the separation of specific cell types from complex biological samples. The market is expanding due to growing applications in stem cell research, cancer biology, immunology, and personalized medicine. Additionally, improvements in magnetic-activated cell sorting (MACS), fluorescence-activated cell sorting (FACS), and microfluidic technologies are making cell isolation more efficient, reproducible, and scalable. To request a free sample copy of this report,...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more